{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:09:00Z","timestamp":1792451340657,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bmcl.2020.127728","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T18:57:34Z","timestamp":1608231454000},"page":"127728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["ATB0,+-targeted delivery of triptolide prodrugs for safer and more effective pancreatic cancer therapy"],"prefix":"10.1016","volume":"33","author":[{"given":"Dan","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-7276","authenticated-orcid":false,"given":"Yuanzhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Shangguan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfa","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bmcl.2020.127728_b0005","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s13346-020-00827-z","article-title":"Therapeutic applications and delivery systems for triptolide","volume":"10","author":"Viegas","year":"2020","journal-title":"Drug Deliv Transl Res"},{"issue":"5","key":"10.1016\/j.bmcl.2020.127728_b0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","article-title":"Triptolide and Its Derivatives as Cancer Therapies","volume":"40","author":"Noel","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"23","key":"10.1016\/j.bmcl.2020.127728_b0015","doi-asserted-by":"crossref","first-page":"9334","DOI":"10.1021\/acs.jmedchem.5b01329","article-title":"Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts","volume":"58","author":"Patil","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127728_b0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fphar.2018.00027","article-title":"Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types","volume":"9","author":"Kou","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2020.127728_b0025","doi-asserted-by":"crossref","unstructured":"Kou L, Yao Q, Zhang H, Chu M, Bhutia YD, Chen R, et al. Transporter-Targeted Nano-Sized Vehicles for Enhanced and Site-Specific Drug Delivery. Cancers. 2020; 12: 2837.","DOI":"10.3390\/cancers12102837"},{"key":"10.1016\/j.bmcl.2020.127728_b0030","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/acs.jmedchem.7b00049","article-title":"Combination of l-Carnitine with Lipophilic Linkage-Donating Gemcitabine Derivatives as Intestinal Novel Organic Cation Transporter 2-Targeting Oral Prodrugs","volume":"60","author":"Wang","year":"2017","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.bmcl.2020.127728_b0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/14728222.2018.1502273","article-title":"Recent advances in drug delivery via the organic cation\/carnitine transporter 2 (OCTN2\/SLC22A5)","volume":"22","author":"Kou","year":"2018","journal-title":"Exp Opin Therap Targets"},{"key":"10.1016\/j.bmcl.2020.127728_b0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/10717544.2019.1710623","article-title":"OCTN2-targeted nanoparticles for oral delivery of paclitaxel: differential impact of the polyethylene glycol linker size on drug delivery in vitro, in situ, and in vivo","volume":"27","author":"Kou","year":"2020","journal-title":"Drug Deliv"},{"issue":"27","key":"10.1016\/j.bmcl.2020.127728_b0045","doi-asserted-by":"crossref","first-page":"30031","DOI":"10.1021\/acsami.0c03564","article-title":"Tumor Microenvironment-Responsive, Multistaged Liposome Induces Apoptosis and Ferroptosis by Amplifying Oxidative Stress for Enhanced Cancer Therapy","volume":"12","author":"Kou","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"10.1016\/j.bmcl.2020.127728_b0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/17425247.2020.1723544","article-title":"Endocytosis of ATB 0,+ (SLC6A14)-targeted liposomes for drug delivery and its therapeutic application for pancreatic cancer","volume":"17","author":"Kou","year":"2020","journal-title":"Exp Opinion Drug Deliv"},{"key":"10.1016\/j.bmcl.2020.127728_b0055","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1080\/10717544.2017.1377316","article-title":"Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB(0,+) to deliver chemotherapeutic agents for colon cancer therapy","volume":"24","author":"Kou","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.bmcl.2020.127728_b0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2019.12.007","article-title":"Therapeutic options and drug delivery strategies for the prevention of intrauterine adhesions","volume":"318","author":"Kou","year":"2020","journal-title":"J Control Release"},{"issue":"8","key":"10.1016\/j.bmcl.2020.127728_b0065","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.tips.2018.06.003","article-title":"MMP-Responsive \u2018Smart\u2019 Drug Delivery and Tumor Targeting","volume":"39","author":"Yao","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.bmcl.2020.127728_b0070","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1124\/jpet.103.057109","article-title":"Transport of Amino Acid-Based Prodrugs by the Na + - and Cl - -Coupled Amino Acid Transporter ATB 0,+ and Expression of the Transporter in Tissues Amenable for Drug Delivery","volume":"308","author":"Hatanaka","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.bmcl.2020.127728_b0075","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7","article-title":"Transport of Valganciclovir, a Ganciclovir Prodrug, via Peptide Transporters PEPT1 and PEPT2","volume":"89","author":"Sugawara","year":"2000","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.bmcl.2020.127728_b0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/jpet.104.067934","article-title":"XP13512 [(\u00b1)-1-([(\u03b1-Isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane Acetic Acid], A Novel Gabapentin Prodrug: I. Design, Synthesis, Enzymatic Conversion to Gabapentin, and Transport by Intestinal Solute Transporters","volume":"311","author":"Cundy","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.bmcl.2020.127728_b0085","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1158\/0008-5472.CAN-14-3745","article-title":"Amino Acid Transporters in Cancer and Their Relevance to \u201cGlutamine Addiction\u201d: Novel Targets for the Design of a New Class of Anticancer Drugs","volume":"75","author":"Bhutia","year":"2015","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bmcl.2020.127728_b0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","article-title":"Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond","volume":"121","author":"Ganapathy","year":"2009","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.bmcl.2020.127728_b0095","first-page":"145","article-title":"The role of transporters in cancer redox homeostasis and cross-talk with nanomedicines","volume":"15","author":"Kou","year":"2020","journal-title":"Asian J Pharm Sci"},{"issue":"2","key":"10.1016\/j.bmcl.2020.127728_b0100","first-page":"192","article-title":"Amino acid transporters: Emerging roles in drug delivery for tumor-targeting therapy","volume":"15","author":"Zhang","year":"2020","journal-title":"Asian J Pharm Sci"},{"issue":"2","key":"10.1016\/j.bmcl.2020.127728_b0105","first-page":"129","article-title":"Special topic: Emerging role of transporters in drug interaction and delivery","volume":"15","author":"Kou","year":"2020","journal-title":"Asian J Pharm Sci"},{"issue":"30","key":"10.1016\/j.bmcl.2020.127728_b0110","doi-asserted-by":"crossref","first-page":"26722","DOI":"10.1021\/acsami.9b09784","article-title":"Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy","volume":"11","author":"Kou","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.bmcl.2020.127728_b0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jconrel.2020.08.054","article-title":"Therapeutic application and construction of bilirubin incorporated nanoparticles","volume":"328","author":"Yao","year":"2020","journal-title":"J Control Release"},{"issue":"1-2","key":"10.1016\/j.bmcl.2020.127728_b0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbadis.2005.04.002","article-title":"Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans","volume":"1741","author":"Gupta","year":"2005","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.bmcl.2020.127728_b0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2005.08.016","article-title":"Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix","volume":"100","author":"Gupta","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bmcl.2020.127728_b0130","doi-asserted-by":"crossref","unstructured":"Karunakaran S, Umapathy NS, Thangaraju M, Hatanaka T, Itagaki S, Munn DH, et al. Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy. Biochem J 2008; 414: 343-55.","DOI":"10.1042\/BJ20080622"},{"issue":"6","key":"10.1016\/j.bmcl.2020.127728_b0135","first-page":"293","article-title":"The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy","volume":"9","author":"Bhutia","year":"2014","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.bmcl.2020.127728_b0140","doi-asserted-by":"crossref","unstructured":"Cai A, Zheng H, Chen Z, Lin X, Li C, Yao Q, et al. Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreatic cancer cells. The Biochem J 2020; 477: 1923-37.","DOI":"10.1042\/BCJ20200275"},{"key":"10.1016\/j.bmcl.2020.127728_b0145","doi-asserted-by":"crossref","unstructured":"Sun Y, Ke Y, Li C, Wang J, Tu L, Hu L, et al. Bifunctional and Unusual Amino Acid \u03b2- or \u03b3-Ester Prodrugs of Nucleoside Analogues for Improved Affinity to ATB0,+ and Enhanced Metabolic Stability: An Application to Floxuridine. J Med Chem 2020; 63: 10816-28.","DOI":"10.1021\/acs.jmedchem.0c00149"},{"key":"10.1016\/j.bmcl.2020.127728_b0150","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/1389200211314060004","article-title":"Prodrug design targeting intestinal PepT1 for improved oral absorption: design and performance","volume":"14","author":"Zhang","year":"2013","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.bmcl.2020.127728_b0155","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2016.10.031","article-title":"Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB0,+-mediated tumor targeting of liposomes for docetaxel delivery for hepatocarcinoma therapy","volume":"243","author":"Luo","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.bmcl.2020.127728_b0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1469-7793.2001.0297f.x","article-title":"Na+- and Cl\u2013coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes","volume":"532","author":"Nakanishi","year":"2001","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.bmcl.2020.127728_b0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1039\/C6BM00788K","article-title":"ATB 0,+ transporter-mediated targeting delivery to human lung cancer cells via aspartate-modified docetaxel-loading stealth liposomes","volume":"5","author":"Luo","year":"2017","journal-title":"Biomater Sci"},{"issue":"2","key":"10.1016\/j.bmcl.2020.127728_b0170","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/bbrc.1998.8628","article-title":"Valacyclovir: A Substrate for the Intestinal and Renal Peptide Transporters PEPT1 and PEPT2","volume":"246","author":"Ganapathy","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.bmcl.2020.127728_b0175","first-page":"555","article-title":"PEPT1-mediated prodrug strategy for oral delivery of peramivir","volume":"13","author":"Sun","year":"2018","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.bmcl.2020.127728_b0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejmech.2018.06.064","article-title":"Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery","volume":"156","author":"Foley","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2020.127728_b0185","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1073\/pnas.1813715116","article-title":"Structural basis for prodrug recognition by the SLC15 family of proton-coupled peptide transporters","volume":"116","author":"Minhas","year":"2019","journal-title":"PNAS"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20308398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20308398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:38:09Z","timestamp":1760773089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20308398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":37,"alternative-id":["S0960894X20308398"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127728","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATB0,+-targeted delivery of triptolide prodrugs for safer and more effective pancreatic cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127728"}}